Ablation Strategies Inc. pioneers MRI-guided stereotactic radioablation for treating refractory atrial fibrillation and ventricular tachycardia. Our innovative technology delivers targeted treatment with unprecedented precision while minimizing exposure to healthy cardiac tissue.
Advanced Technology Platform
Our MRI-Linac technology provides real-time imaging guidance for accurate target identification and treatment delivery. This advanced imaging capability ensures superior visualization of cardiac structures compared to traditional X-ray based systems.
Stereotactic radioablation delivers high-dose radiation to target lesions while preserving surrounding healthy tissue. Our treatment planning optimizes dose distribution to protect critical cardiac structures and organs at risk.
Patients receive their complete treatment in a single session, eliminating the need for multiple procedures. This streamlined approach reduces overall treatment time and improves patient convenience and outcomes.
Our multi-disciplinary team utilizes advanced imaging fusion and inverse treatment planning to create customized ablation strategies. Each treatment plan is meticulously designed to target the specific anatomical source of arrhythmia.
Our treatment approach is grounded in rigorous clinical research and preclinical animal studies demonstrating safety and efficacy. We follow internationally recognized guidelines and best practices in cardiac ablation therapy.
Ablation Strategies Inc. is conducting prospective clinical trials at leading academic medical centers to validate our technology. Our research demonstrates promising results in patients who have failed conventional catheter ablation and medication therapy.
Our physicians include board-certified electrophysiologists and radiation oncologists with extensive experience in cardiac arrhythmia management. We collaborate with independent clinical reviewers to ensure the highest standards of patient care and safety.
Patient-Centered Care
Clinical Success Stories
The treatment was remarkably efficient and well-tolerated with minimal side effects. I experienced significant improvement in my arrhythmia symptoms within the first month following the procedure.
Dr. Robert MitchellCardiologist, Academic Medical CenterThis innovative technology offers hope to patients like me who had exhausted all other treatment options. The precision and safety of the MRI-guided approach gave me confidence in the procedure.
Sarah JohnsonPatient, Refractory Atrial FibrillationCommon Questions